WELL Health Technologies Corp (WELL:CA) Stock Forecast
Show ratings and price targets of :
Alert
Its only available to paid users.
CAD 7.33
(+3.22%)
Based on the WELL Health Technologies Corp stock forecast from 9 analysts, the average analyst target price for WELL Health Technologies Corp is CAD 7.33 over the next 12 months. WELL Health Technologies Corp’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of WELL Health Technologies Corp is Slightly Bullish , which is based on 8 positive signals and 6 negative signals. At the last closing, WELL Health Technologies Corp’s stock price was CAD 7.10. WELL Health Technologies Corp’s stock price has changed by +4.57% over the past week, +37.33% over the past month and +84.42% over the last year.
No recent analyst target price found for WELL Health Technologies Corp
No recent average analyst rating found for WELL Health Technologies Corp
Company Overview WELL Health Technologies Corp
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare. The company also develops, integrates, and sells its own suite of technology software and technology solutions to medical clinics and healthcare practitioners. In addition, it operates practitioner enablement platform, including Electronic Medical Records (EMR); telehealth platforms; practice management; AI-powered virtual assistant (WELL AI Voice); Apps.health, a digital health app marketplace; billing and revenue cycle management solutions for billing and back-office services comprising billing-as-a-service outsourcing services to doctors; and cybersecurity protection and patient data privacy solutions, as well as OSCAR Pro, an EMR platform. The company was founded in 2010 and is headquartered in Vancouver, Canada. Read Less
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal hea...Read More
Frequently Asked Questions About WELL Health Technologies Corp (WELL:CA) Stock
Based on ratings from 9 analysts WELL Health Technologies Corp's stock is Buy . Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 10 buy, 1 sell and 4 hold ratings.
Unfortunately we do not have enough data on WELL:CA's stock to indicate if its a good dividend stock.
Based on targets from 9 analysts, the average taret price for WELL:CA is CAD 7.33 over the next 12 months. The maximum analyst target price is CAD 11 while the minimum anlayst target price is CAD 4.75.
WELL:CA stock's Price/Earning ratio is 21.90.
Our analysis grades WELL:CA stock's Price / Earning ratio at F. This means that WELL:CA stock's Price/Earning ratio is above 50% of the stocks in the Medical Care Facilities sector in the TSX exchange.
Based on this WELL:CA may be fairly valued for its sector
The last closing price of WELL:CA's stock was CAD 7.10.
The most recent market capitalization for WELL:CA is CAD 1.69B.
Based on targets from 9 analysts, the average taret price for WELL:CA is projected at CAD 7.33 over the next 12 months.
This means that WELL:CA's stock price may go up by +3.22% over the next 12 months.
We can't find any ETFs which contains WELL Health Technologies Corp's stock.
As per our most recent records WELL Health Technologies Corp has 0 Employees.
WELL Health Technologies Corp's registered address is 375 Water Street, Vancouver, BC, Canada, V6B 5C6.
You can get more information about it from WELL Health Technologies Corp's website at https://well.company.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About WELL Health Technologies Corp (WELL:CA) Stock
Based on ratings from 9 analysts WELL Health Technologies Corp's stock is Buy . Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 10 buy, 1 sell and 4 hold ratings.
Unfortunately we do not have enough data on WELL:CA's stock to indicate if its a good dividend stock.
Based on targets from 9 analysts, the average taret price for WELL:CA is CAD 7.33 over the next 12 months. The maximum analyst target price is CAD 11 while the minimum anlayst target price is CAD 4.75.
WELL:CA stock's Price/Earning ratio is 21.90.
Our analysis grades WELL:CA stock's Price / Earning ratio at F. This means that WELL:CA stock's Price/Earning ratio is above 50% of the stocks in the Medical Care Facilities sector in the TSX exchange.
Based on this WELL:CA may be fairly valued for its sector
The last closing price of WELL:CA's stock was CAD 7.10.
The most recent market capitalization for WELL:CA is CAD 1.69B.
Based on targets from 9 analysts, the average taret price for WELL:CA is projected at CAD 7.33 over the next 12 months.
This means that WELL:CA's stock price may go up by +3.22% over the next 12 months.
We can't find any ETFs which contains WELL Health Technologies Corp's stock.
As per our most recent records WELL Health Technologies Corp has 0 Employees.
WELL Health Technologies Corp's registered address is 375 Water Street, Vancouver, BC, Canada, V6B 5C6.
You can get more information about it from WELL Health Technologies Corp's website at https://well.company.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for WELL:CA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
